Advent International, a private equity firm based in Boston, Massachusetts, is considering a buyout deal for drugmaker Swedish Orphan Biovitrum.
Advent has approached other buyout firms including Permira in an attempt to lead a consortium for the acquisition of the Swedish biotech firm.
Subscribe to our Newsletter to increase your edge. Don’t worry about the news anymore, through our newsletter you’ll receive weekly access to what is happening. Join 120,000 other PE professionals today.
It is also weighing to bring in sovereign wealth funds for the bid. The talks are at an early stage, and it is not yet clear that they will ultimately lead to a deal, according to the people.
Source: Seeking Alpha
Can’t stop reading? Read more
Carlyle and Goldman Sachs open private credit funds to Willow users with $10,000 minimum
Carlyle and Goldman Sachs open private credit funds to Willow users with $10,000 minimum Carlyle,...
EQT, PAI, and Stone Point shortlisted for €2bn takeover of Castik-backed Global Group
EQT, PAI, and Stone Point shortlisted for €2bn takeover of Castik-backed Global Group EQT, PAI...
CAIS Advisors unveils retail vehicle giving investors a stake in elite sports and media
CAIS Advisors unveils retail vehicle giving investors a stake in elite sports and media Eldridge...